Brivaracetam study for children with hard-to-control seizures
Treatments studied
Part of Brain & nervous system clinical trials.
This trial looks at how safe brivaracetam is and how well it can be used in children and teens with certain types of epilepsy that are not well controlled. It may help families who are dealing with frequent focal seizures despite taking seizure medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are enrolling for the study in Japan and your age is 4 to under 16 years
- Your seizure diagnosis fits focal epilepsy, supported by an EEG reading within the last 10 years
- Your seizures are still not controlled (you have had partial/focal seizures) even after trying at least one seizure medicine
- You had at least one focal seizure during the 4-week screening period
- You are not in another medication/device study besides this brivaracetam study
- You do not have major health problems (neurological, psychiatric, lab/heart tests) that could affect safety
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.
This trial tests an oral cannabidiol medicine (Epidiolex) for children whose seizures are not controlled by other treatments. It aims to see if adding this drug can reduce seizure frequency.
This study tests an investigational drug called AV078 for people with tuberous sclerosis complex (TSC) whose seizures are not controlled by at least two current medications. The goal is to see if AV078 can reduce seizure frequency safely, and participants continue their usual seizure medications during the trial.
This study looks at abnormal electrical activity in the brain that can happen in people with mild cognitive impairment or Alzheimer's disease. It aims to better understand this activity, which might help improve future treatments.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.